Lung cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1)Adaptable of stereotactic radiotherapy for primary or metastatic lung malignant tumor less of equal 5cm. Fulfilling both of the following conditions and clinically diagnosed as NSCLC. a) increase in tumor size of 1 mm or more, or consolidation/tumor ratio turning >50% from <=50% on CT scans performed 28 days or more apart. b) positive accumulation on FDG-PET. 2)Performance status (ECOG): 0-2 3)Enable for performing PET/CT 4)Aged 20 to 84 5)signed informed consent
Exclusion criteria
Exclusion criteria: 1)During the pregnancy or a pregnant female patient we are possible or are nursing. 2)The patient whom we merge psychosis or neurological manifestation, and it is judged to have difficulty with participation to an examination. 3)Severe complications whom enable to perform PET/CT 4)Other reasons with inadequate to enroll this trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change of 18F-MISO uptake between before and after treatment | — |
Countries
Japan
Contacts
Kindai University Department of Radiation Oncology,